Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions

Chronic Kidney Disease(CKD)Depression

Interventions

OTHER

Antidepressants

control

All Listed Sponsors

lead

Wonju Severance Christian Hospital

OTHER

NCT06675396 - Pharmacogenomics of Mood Disorder in Chronic Kidney Disease Patients | Biotech Hunter | Biotech Hunter